mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0081 |
0.8 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.8 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.8 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |